Content & Events
Careers
Investors
Contact
About
+
-
Get To Know Us
Leadership Team
Board Of Directors
Commercial & PM Teams
A Welcoming CDMO: It's The Texas In Us
Careers
Clinical Biomanufacturing
+
-
Clinical Biomanufacturing
+
-
Capabilities Overview
cGMP Mammalian Cell Culture
cGMP Microbial Fermentation
Process Development
+
-
Mammalian Cell Culture Development
Microbial Fermentation Development
Downstream Process Development
Commercial Manufacturing
Bioanalytical Services
+
-
Methods Development
Technologies
Pre-Clinical & Product Development Services
+
-
Toxicokinetic Studies (TK)
Cell-Based Potency Assays
CMC Analytical Support Services
+
-
Release Testing
Stability Testing
Bioassays
Content & Events
Careers
Investors
Contact
Content & Events
What's New At Scorpius
All Media
News
Events
Articles
Blogs
Resources
Videos
October 1, 2024
Scorpius Holdings Selected to Join Medical CBRN Defense Consortium
Scorpius announces that it has been selected to join Medical CBRN Defense Consortium to advance medical countermeasures against chemical, biological, radiological, and nuclear threats.
October 3, 2024
articles
Scorpius' Ania Szymanska Featured in Pharmaceutical Technology’s February 2024 E-book
Scorpius BioManufacturing's Site Head of Quality, Ania Szymanska shares her expertise on how to evaluate a CDMO’s commitment to quality in Pharmaceutical Technology’s February 2024 E-book.
March 4, 2024
resources
Brochure: Comprehensive Capabilities from Discovery to Commercial Manufacturing
DOWNLOAD
blogs
Meeting the Needs of Small-Volume Mammalian Cell Culture Manufacturing
Bridging the gap in small-volume production of biologics with mammalian cell culture.
August 1, 2024
articles
The Rapidly Evolving Landscape of Contract Biologics Manufacturing
In this 15-minute webcast, biopharma industry veteran Joe Payne, President & COO of Scorpius BioManufacturing, explains his take on the contract biologics manufacturing industry.
September 9, 2024
Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-Consortium
Scorpius announces that it has been accepted into the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), a part of the National Biopharmaceutical Manufacturing Partnership.
September 10, 2024
Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA
Scorpius announces that it has been selected as a member of the Biomedical Advanced Research and Development Authority’s (BARDA) Rapid Response Partnership Vehicle (RRPV).
September 10, 2024
videos
Outsourced Pharma Capacity Update
This 15-minute presentation includes a virtual tour of Scorpius’ process development lab, analytical and QC lab, and some of our cGMP mammalian manufacturing areas.
September 9, 2024
videos
BIO 2024 Wrap-up
Scorpius BioManufacturing 2024 BIO International Convention wrap-up video.
June 7, 2024
news
Scorpius BioManufacturing Appoints New VP of Business Development Shari Udoff-McDonald
Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), appointed a new VP of Business Development Shari Udoff-McDonald.
May 6, 2024
videos
We're Scorpius
We're Scorpius, a boutique biologics CDMO.
May 2, 2024
videos
Scorpius BioManufacturing Facility Overview
Take a look into Scorpius' CDMO facilities in San Antonio, TX.
May 2, 2024
videos
BIO 2024 Lego QC Lab Part 1
Scorpius is partnering with BrevisRefero to build a quality control lab made entirely out of lego bricks for BIO 2024.
May 2, 2024
videos
Joe Payne PharmTech Interview - DCAT 2024
Q&A with Scorpius' President and COO Joe Payne.
May 2, 2024
NightHawk Biosciences Completes Name Change to Scorpius Holdings
NightHawk Biosciences announced its name change to Scorpius Holdings, Inc., to better reflect the company’s successful shift into a pure-play, large molecule biomanufacturing CDMO.
February 6, 2024
news
Scorpius BioManufacturing Announces Joe Payne as President and Chief Operating Officer
Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), promoted Joe Payne to President and COO.
February 1, 2024
articles
From frustration to innovation: a CDMO’s mission to empower emerging biotechs
Capacity, capacity, capacity. This seems to be all the industry talks about. A global pandemic magnified the need for more biologics manufacturing capacity. Capacity, however, isn’t the whole story.
October 20, 2023
articles
Does Your Biologics CDMO Truly Have a Culture of Quality?
Joe Payne, Scorpius' President & COO, shares what 20+ years in pharma has taught him about creating a culture of quality.
July 27, 2023
news
Scorpius Expands Leadership Team With New VP, Manufacturing Operations
Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), expanded its leadership to include Matthew R. LeClair.
July 7, 2023
videos
Scorpius Corporate Video
Learn more about our boutique biologics facility in San Antonio, TX
July 6, 2023
articles
Biologics Outsourcing: Decision Drivers and Key Considerations
A recent survey of 100 decision makers at innovative biologics companies revealed 57% of respondents believe their companies’ outsourcing activities will increase over the next two years, while a furt...
April 17, 2023
articles
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
By providing end-to-end services — including secure supply chains — CRO/CDMOs, like Scorpius BioManufacturing can help biologics developers meet accelerated timelines and establish a real competitive ...
January 31, 2023
articles
The Bioanalytical Development Journey
Biopharma companies outsource pharmaceutical development and manufacturing from discovery, bioanalytical testing, qualification to validation.
May 18, 2022
articles
Evaluating Single-Use Technologies for Biomanufacturing
Single-use technologies (SUTs) are ideal for multiproduct facilities producing smaller volumes of materials.
November 22, 2021
articles
ABC: Analytics for Biomanufacturing and Clinical Trials of Biomanufactured Products
Samir Lakhashe, Director, Bioanalysis, discusses assay categorization, the company's growing toolbox, predictions for the future, and what scientists who want to join the growing team should know, wit...
October 15, 2021